Profound Medical Corp. PRN.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 39.22% | 34.23% | -65.25% | 14.83% | -126.84% |
| Total Depreciation and Amortization | -4.26% | -38.65% | -54.20% | -31.31% | -39.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.80% | 7.30% | 174.30% | 151.05% | 77.61% |
| Change in Net Operating Assets | -881.42% | -318.64% | 107.36% | -307.83% | 205.48% |
| Cash from Operations | 17.51% | -3.62% | -11.69% | -40.84% | -121.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -- | 8.24% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 66.53% | -- | -- |
| Cash from Financing | -- | -- | 16.91% | 100.00% | 100.00% |
| Foreign Exchange rate Adjustments | -127.37% | -998.94% | 115.68% | -263.42% | 998.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.99% | -11.19% | 25.58% | -49.07% | -58.26% |